Increased protein and mRNA expression of endostatin in the ischemic brain tissue of rabbits after middle cerebral artery occlusion

Neuroscience Bulletin

Volumn 23, Issue 1, 2007, Pages 35-40

  Tian, Heng Li ^a,b   Chen, Hao ^b   Cui, Yu Hui ^b   Xu, Tao ^b   Zhou, Liang Fu ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Angiogenesis; Endostatin; Focal cerebral ischemia; Vascular endothelial growth factor

Indexed keywords

ENDOSTATIN; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CEREBRAL ARTERIES; ENDOSTATINS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33847779891     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12264-007-0005-2     Document Type: Article

References (30)

1. Wei L, Erinjeri JP, Rovainen CM, Woolsey TA. Collateral growth and angiogenesis around cortical stroke. Stroke 2001, 32: 2179-2184.
2. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994, 25: 1794-1798.
3. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000, 407: 249-257.
4. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86: 353-364.
5. Greenberg DA, Jin K. From angiogenesis to neuropathology. Nature 2005, 438: 954-959.
6. Guo X, Lu SD, Sun FY. Intraventricular injection of liposome-mediated VEGF plasmids enhances brain repair following ischemia-reperfusion injury. Chin J Neurosci 2004, 20: 416-421.
7. Manoonkitiwongsa PS, Schultz RL, McCreey DB, Whitter EF, Lyden PD. Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis. J Cereb Blood Flow Metab 2004, 24: 693-702.
8. Storkebaum E, Lambrechts D, Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 2004, 26: 943-954.
9. Sun FY, Guo X. Molecular and Cellular Mechanisms of Neuroprotection by vascular endothelial growth factor. J Neurosci Res 2005, 79: 180-184.
10. O'Brien MD, Waltz AG. Transorbital approach for occluding the middle cerebral artery without craniectomy. Stroke 1973, 4: 201-206.
11. Risau W. Mechanisms of angiogenesis. Nature 1997, 386: 671-674.
12. Kazemi S, Wenzel D, Kolossov E, Lenka N, Raible A, Sasse P, et al. Differential role of bFGF and VEGF for vasculogenesis. Cell Physiol Biochem 2002, 12: 55-62.
13. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 2000, 156: 965-976.
14. 3 during focal cerebral ischemia. J Cereb Blood Flow Metab 1999, 19: 1038-1050.
15. Kovacs Z, Ikezaki K, Samoto K, Inamura T, Fukui M. VEGF and flt. Expression time kinetics in rat brain infarct. Stroke 1996, 27: 1865-1872.
16. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, et al. VEGF-induced neuroprotection, neurogensis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003, 111: 1843-1851.
17. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88: 277-285.
18. Skovseth DK, Veuger MJ, Sorensen DR, De Angelis PM, Haraldsen G. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood 2005, 105:1044-1051.
19. Dhanabal M, Ramchandran R, Waterman MJ, Lu H, Knebelmann B, Segal M, et al. Endostatin induces endothelial cell apoptosis. J Biol Chem 1999, 274: 11721-11726.
20. Kim YM, Hwang S, Kim YM, Pyun BJ, Kim TY, Lee ST, et al. Endostatin blocks VEGF-mediated signaling via direct interaction with KDR/FIK-1. J Biol Chem 2002, 277: 27872-27879.
21. Dobryansky M, Galiano RD, Cetrulo CL, Bhatt KA, Michaels J, Ashinoff R, et al. Endostatin inhibits ischemia-induced neovascularization and increases ischemic tissue loss. Ann Plast Surg 2004, 52: 512-518.
22. Arenillas JF, Alvarez-Sabin J, Montaner J, Resell A, Molina CA, Rovira A, et al. Angiogenesis in symptomatic intracranial atherosclerosis: predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence. Stroke 2005, 36: 92-97.
23. Takeshita S, Kawamura Y, Takabayashi H, Yoshida N, Nonoyama S. Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease. Clin Exp Immunol 2005, 139: 575-579.
24. Panchal VR, Rehman J, Nguyen AT, Brown JW, Turrentine MW, Mahomed Y, et al. Reduced pericardial levels of endostatin correlate with collateral development in patients with ischemic heart disease. J Am Coll Cardiol 2004, 43: 1383-1387.
25. Feldman AL, Pak H, Yang JC, Alexander HR Jr, Libutti SK. Serum endostatin levels are elevated in patients with soft tissue sarcoma. Cancer 2001, 91: 1525-1529.
26. Feldman AL, Alexander HR Jr, Yang JC, Linehan WM, Eyler RA, Miller MS, et al. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. Cancer 2002, 95: 1637-1643.
27. Bono P, Teerenhovi L, Joensuu H. Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma. Cancer 2003, 97: 2767-2775.
28. Tsuboi S, Nouso K, Tomono Y, Nagamori S, Naito I, Watanabe T, et al. Anti-endostatin monoclonal antibody enhances growth of human hepatocellular carcinoma cells by inhibiting activity of endostatin secreted by the transplanted cells in nude mice. Int J Oncol 2004, 25: 1267-1271.
29. Dutour A, Monteil J, Paraf F, Charissoux JL, Kaletta C, Sauer B, et al. Endostatin cDNA/cationic liposome complexes as a promising to prevent lung metastases in osteosarcoma: study in a human-like rat orthotopic tumor. Mol Ther 2005, 11: 311-319.
30. Wu Y, Yang L, Zhao X, Su JM, Hu B, Liu JY, et al. Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus. Chin J Med Genet 2004, 21: 557-561.